Wilson Wolf cell culture systems for patient cell therapy manufacturing for clinical trials

The National Institutes of Health (NIH) is seeking to award a Firm Fixed Price contract for the provision of Wilson Wolf cell culture systems for patient cell therapy manufacturing for clinical trials. The requirement includes 210 G-Rex100 (3-pack box) with 100cm² gas permeable membrane surface area and 450 mL media capacity. The contract will be awarded to the responsible offeror whose proposal represents the best value to the Government, considering factors such as technical capability, price, past performance, and delivery schedule. • The G-Rex100 system has a gas permeable membrane surface area with 450 mL media capacity. • The system can expand 50 million cells into between 2 to 4 billion cells in about 12 days with only two exchanges of medium. • The offeror must provide unit and total price, shipping and handling costs, delivery timeframe after award, delivery terms, F.O.B. point, product or catalog numbers, and product/service description. • The offeror must be actively registered in the System for Award Management (SAM) at www.sam.gov.